Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05250284 · ClinicalTrials.gov registry record
The Intersection of Oncology Care and Worker Well-Being
A clinical trial of Solid Tumor, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT05250284 is a study of Solid Tumor that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 400 participants, above the 220-participant average among 196 other Solid Tumor trials with a reported enrollment target (82% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05250284, a study of Solid Tumor, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The goals of this study will be a greater understanding of cancer patients' well-being experience through the care/treatment continuum. An important aspect of the study is an understanding of work- and treatment-related challenges experienced by low-income men, many of whom will be Latino. At the 12-month observation period, the investigators will learn whether these men work long-term and how work status relates to well-being.
Conditions Studied
Interventions
- BEHAVIORAL WellBQ
- BEHAVIORAL PROMIS
Study Locations (1)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2022-04-04 |
| Est. Completion | 2027-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05250284
The ClinicalTrials.gov registry entry for NCT05250284 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 220-participant average among 196 other Solid Tumor trials with a reported enrollment target (82% higher). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Solid Tumor appearing as the primary indexed condition, and to 2 interventions - of which WellBQ is the first listed.
NCT05250284 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT05250284 about?
NCT05250284 is a clinical study titled "The Intersection of Oncology Care and Worker Well-Being". The goals of this study will be a greater understanding of cancer patients' well-being experience through the care/treatment continuum. An important aspect of the study is an understanding of work- and treatment-related challenges experienced by low-income men, many of whom will be Latino. At the 12...
What is the current status of trial NCT05250284?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2022-04-04. Estimated completion is 2027-08.
What conditions does trial NCT05250284 study?
This clinical trial studies the following conditions: Solid Tumor.
What interventions are being tested in trial NCT05250284?
The interventions under investigation include: WellBQ (BEHAVIORAL), PROMIS (BEHAVIORAL).
Who is sponsoring clinical trial NCT05250284?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05250284 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
RECRUITING · Phase 2
-
Dabrafenib and/or Trametinib Rollover Study
RECRUITING · Phase 4
-
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
RECRUITING · Phase 3
-
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
RECRUITING · Phase 1
-
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.